Gujarat Themis Biosyn Ltd.
Status: Publicly traded
Direct answer
Gujarat Themis Biosyn Ltd. is publicly traded on NSE under the ticker GUJTHEM.NS.
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O,...
Can you invest in Gujarat Themis Biosyn Ltd.?
Yes. Gujarat Themis Biosyn Ltd. trades publicly on NSE as GUJTHEM.NS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Gujarat Themis Biosyn Ltd.
Detailed equity research is provided by MarketSnap.